The Journal of Immunology, Vol 147, Issue 5 1477-1483, Copyright © 1991 by American Association of Immunologists

ARTICLES

The 1A4 molecule (CD27) is involved in T cell activation

K Sugita, Y Torimoto, Y Nojima, JF Daley, SF Schlossman and C Morimoto
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.

We developed a new mAb, anti-1A4, which recognizes an epitope on the CD27 molecule distinct from those recognized by several known anti-CD27 mAb. Although it has been suggested that the CD27 molecule is a T cell activation Ag, there was little direct evidence that the structure was involved in the T cell activation process. In this study, we showed that anti-1A4 inhibited anti-CD2, anti-CD3, mitogens, or soluble Ag- induced T cell proliferation as well as PWM-driven B cell IgG synthesis. Interestingly, anti-1A4 inhibited IL-2 secretion without affecting IL-2R expression. In addition, pretreatment of T cells with anti-1A4 inhibited the normally sustained intracellular calcium mobilization seen after triggering of T cells via the CD2 or CD3 pathways. Thus, binding of anti-1A4 to the CD27 molecule appears to induce a negative effect on T cell activation. This may be due to either a direct signal to T cells or the blocking of an interaction between T cells and accessory cells or both. These findings support the notion that the CD27 molecule plays an integral role in the process of T cell activation.

This article has been cited by other articles:

				E. Alici, T. Sutlu, B. Bjorkstrand, M. Gilljam, B. Stellan, H. Nahi, H. C. Quezada, G. Gahrton, H.-G. Ljunggren, and M. S. Dilber Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components Blood, March 15, 2008; 111(6): 3155 - 3162. [Abstract] [Full Text] [PDF]

				Y. Kaufmann, N. Amariglio, E. Rosenthal, Y. J. Hirsch, A. Many, and G. Rechavi Proliferation Response of Leukemic Cells to CD70 Ligation Oscillates with Recurrent Remission and Relapse in a Low-Grade Lymphoma J. Immunol., November 15, 2005; 175(10): 6940 - 6947. [Abstract] [Full Text] [PDF]

				Y. Shi, T. Yamazaki, Y. Okubo, Y. Uehara, K. Sugane, and K. Agematsu Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell J. Immunol., September 1, 2005; 175(5): 3262 - 3267. [Abstract] [Full Text] [PDF]

				H. Akiba, Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura Critical Contribution of OX40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis J. Exp. Med., January 17, 2000; 191(2): 375 - 380. [Abstract] [Full Text] [PDF]

				G. Stuhler, A. Zobywalski, F. Grunebach, P. Brossart, V. L. Reichardt, H. Barth, S. Stevanovic, W. Brugger, L. Kanz, and S. F. Schlossman Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters PNAS, February 16, 1999; 96(4): 1532 - 1535. [Abstract] [Full Text] [PDF]

				H. Yamamoto, T. Kishimoto, and S. Minamoto NF-{kappa}B Activation in CD27 Signaling: Involvement of TNF Receptor-Associated Factors in Its Signaling and Identification of Functional Region of CD27 J. Immunol., November 1, 1998; 161(9): 4753 - 4759. [Abstract] [Full Text] [PDF]

				J. A. Harrop, M. Reddy, K. Dede, M. Brigham-Burke, S. Lyn, K. B. Tan, C. Silverman, C. Eichman, R. DiPrinzio, J. Spampanato, et al. Antibodies to TR2 (Herpesvirus Entry Mediator), a New Member of the TNF Receptor Superfamily, Block T Cell Proliferation, Expression of Activation Markers, and Production of Cytokines J. Immunol., August 15, 1998; 161(4): 1786 - 1794. [Abstract] [Full Text] [PDF]

				H. Akiba, H. Nakano, S. Nishinaka, M. Shindo, T. Kobata, M. Atsuta, C. Morimoto, C. F. Ware, N. L. Malinin, D. Wallach, et al. CD27, a Member of the Tumor Necrosis Factor Receptor Superfamily, Activates NF-kappa B and Stress-activated Protein Kinase/c-Jun N-terminal Kinase via TRAF2, TRAF5, and NF-kappa B-inducing Kinase J. Biol. Chem., May 22, 1998; 273(21): 13353 - 13358. [Abstract] [Full Text] [PDF]